Foundation Takes No Stand on Treatments
The Forward’s August 4 article, “Gaucher Disease Patients Get New Hope From Drug,” does not in any way represent the views or opinions of the National Gaucher Foundation. They are, in fact, only those of Cyndi Frank, a patient. Therefore the NGF should not have appeared in that article in any manner.
The NGF does not advocate for any one treatment or pharmaceutical company, as each patient’s needs are different. Only a patient and his or her physician can make an intelligent decision about the proper treatment.
The NGF, a not-for-profit organization, is an unbiased voice for the entire Gaucher community. Our goal is to always present objective and educational information. We worry that the article’s inference that the oral treatment — which has yet to be FDA-approved — is superior to the life-saving drugs that have been and are currently on the market, is misleading. We feel that the article suggests NGF’s endorsement of this treatment. We would like to set the record straight and say that this is not true — it is imperative that we remain unbiased in order to serve the community in the best possible way.
Rhonda P. Buyers
CEO
National Gaucher Foundation
Tucker, Ga.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
— Rachel Fishman Feddersen, Publisher and CEO
